|
Indexed keywords
GENERIC DRUG;
ARTICLE;
CANADA;
DATA ANALYSIS;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
POLICY;
PRIORITY JOURNAL;
TIME;
CANADA;
CROSS-SECTIONAL STUDIES;
DRUG COSTS;
DRUG INDUSTRY;
DRUGS, GENERIC;
ECONOMIC COMPETITION;
HUMANS;
MARKETING;
PRESCRIPTION FEES;
PRESCRIPTIONS, DRUG;
REGRESSION ANALYSIS;
TIME FACTORS;
|
-
1
-
-
0012102951
-
Seeing through the snow
-
Graham J. Seeing through the snow. Regulation 2001; 24: 46-49.
-
(2001)
Regulation
, vol.24
, pp. 46-49
-
-
Graham, J.1
-
2
-
-
0034354072
-
Does regulation drive out competition in pharmaceutical markets?
-
Danzon PM, Chao LW. Does regulation drive out competition in pharmaceutical markets? J Law Econ 2000; 43: 311-358.
-
(2000)
J. Law Econ.
, vol.43
, pp. 311-358
-
-
Danzon, P.M.1
Chao, L.W.2
-
3
-
-
17744403232
-
The impact of generic goods in the pharmaceutical industry
-
Ferrandiz JM. The impact of generic goods in the pharmaceutical industry. Health Econ 1999; 8: 599-612.
-
(1999)
Health Econ.
, vol.8
, pp. 599-612
-
-
Ferrandiz, J.M.1
-
4
-
-
84934453292
-
Brand loyalty, entry. Price competition in pharmaceuticals after the 1984 drug act
-
Grabowski H, Vernon I. Brand loyalty, entry. Price competition in pharmaceuticals after the 1984 drug act. J Law Econ 1992; 35: 331-350.
-
(1992)
J. Law Econ.
, vol.35
, pp. 331-350
-
-
Grabowski, H.1
Vernon, I.2
-
5
-
-
0002257846
-
Patent expiration, entry, and competition in the US pharmaceutical industry
-
Caves R, Whinston M, Hurwitz M. Patent expiration, entry, and competition in the US pharmaceutical industry. Brookings Papers: Microecon 1991; 1-48.
-
(1991)
Brookings Papers: Microecon
, pp. 1-48
-
-
Caves, R.1
Whinston, M.2
Hurwitz, M.3
-
6
-
-
38249041228
-
The importance of being first: The case of prescription drugs in Canada
-
Gorecki P. The importance of being first: the case of prescription drugs in Canada. Int J Ind Organization 1986; 4: 371-395.
-
(1986)
Int. J. Ind. Organization
, vol.4
, pp. 371-395
-
-
Gorecki, P.1
-
7
-
-
0023191394
-
Barriers to entry in the Canadian pharmaceutical industry: Comments, clarification and extensions
-
Gorecki P. Barriers to entry in the Canadian pharmaceutical industry: comments, clarification and extensions. J Health Econ 1987; 6: 59-72.
-
(1987)
J. Health Econ.
, vol.6
, pp. 59-72
-
-
Gorecki, P.1
-
8
-
-
0022034086
-
Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry
-
McRae J, Tapon F. Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry. J Health Econ 1985; 4: 43-61.
-
(1985)
J. Health Econ.
, vol.4
, pp. 43-61
-
-
McRae, J.1
Tapon, F.2
-
9
-
-
0012043149
-
The elderly's perceptions of the risk of generic over-the-counter medication
-
Strutton H, Lumpkin J, Vitell S. The elderly's perceptions of the risk of generic over-the-counter medication. J Res Pharmaceut Econ 1992; 4: 25-39.
-
(1992)
J. Res. Pharmaceut. Econ.
, vol.4
, pp. 25-39
-
-
Strutton, H.1
Lumpkin, J.2
Vitell, S.3
-
10
-
-
25944448451
-
The generic drug industry '94: It's a jungle out there
-
Ukens C. The generic drug industry '94: it's a jungle out there. Drug Topics 1994 (Suppl): 6S-9S.
-
(1994)
Drug Topics
, Issue.SUPPL.
-
-
Ukens, C.1
-
11
-
-
0003661604
-
-
Canadian Institute for Health Information. Ottawa
-
Canadian Institute for Health Information. Health Care in Canada. Ottawa, 2001.
-
(2001)
Health Care in Canada
-
-
-
12
-
-
0012076067
-
-
Canadian Drug Manufacturers Association. Mimeo
-
Canadian Drug Manufacturers Association. Savings to Canada's Health Care System. Mimeo, 1997.
-
(1997)
Savings to Canada's Health Care System
-
-
-
13
-
-
0003559593
-
-
Cambridge University Press: Cambridge
-
Hsiao C. Analysis of Panel Data. Cambridge University Press: Cambridge, 1986.
-
(1986)
Analysis of Panel Data
-
-
Hsiao, C.1
|
